BACKGROUND: Snakebite is a public health problem afflicting mainly rural farmers. We seek 21 to examine the profile and management of snakebite cases presenting to the Tamale Teaching 22 Hospital of Ghana over a 30-month period. 23 24 METHODS: One hundred and ninety-two cases of snakebites presenting to the Tamale Teaching 25 Hospital over a 30-month period from Information about the clinical manifestation of the snakebites, treatment instituted as well as the 27 outcome was extracted from patient folders for the analysis.
to 87 years with an average age of 26.48 ± 16.72 years. More than half of the victims (59.7%) 124 were below 30 years. Table 1 summarizes the demographic and clinical profile of the snakebite 125 victims. 126 About half of the snakebite victims were farmers or herdsmen who were bitten during their work 127 (Table 1 ). The lower limb was the commonest site of bite (67.2%). More than half of bites 128 (53.3%), with documented time of bite, occurred between the hours of 6 pm and 6 am. The received whole blood transfusions.
160
Antibiotics were administered in almost all patients (99.5%). The commonest antibiotic was 161 flucloxacillin, which was used in 74% of snakebite victims, followed by amoxicillin/clavulanate 162 (used in 27.6%). More than half (51%) had at least two different antibiotics whilst 11.5% had at 163 least three different antibiotics.
164
Tetanus prophylaxis was given in about three-quarters of cases as tetanus toxoid (TT) 165 vaccination and anti-tetanus serum (ATS). Analgesia was administered to 92.2% with more than half (55.7%) receiving paracetamol.
167
Opioids were administered in about a quarter (25.5%) whilst 25 (13%) received a nonsteroidal 168 anti-inflammatory agent (NSAID). Steroids were administered in 62%, mainly as intravenous 169 hydrocortisone. Other medications given included vitamin K (28.6%), tranexamic acid (22.9%) 170 and haematinic (15.6%). The 20-minute whole blood clotting time (20WBCT) was deranged in 155 (80.7%) of the 186 snakebite victims. Table 3 summarizes some laboratory indices of the snakebite cases. in Africa [5, 6] . Initial reliance on ineffective traditional remedies accounts partly for this late 204 presentation. We found that at least a third of snakebite victims resorted to the used of traditional 205 herbal remedies prior to presentation to hospital.
206
Identification of the snake species responsible for the bite allows likely course of the 207 envenoming and potential complications to be anticipated and treated. This is usually difficult 208 except when the dead snake is brought along to hospital. Envenomation by the carpet viper or Ghana. It is encouraging that antivenom was available to most of the patients who needed them.
236
The rate of use of antivenom and the number of vials administered in this study was higher than 237 that reported by another study in Ghana [27] . This disparity may be related to the relative 238 efficacy of the antivenoms administered or the fact that antivenom was freely available to 239 snakebite victims in this study.
240
The use of antivenoms is not without risks. Reactions ranging from mild to serious/life patients with coagulopathies may worsen outcome through their prothrombotic effects by 259 causing microvascular thrombosis. Hence, the use of antifibrinolytics and heparin is generally 260 discouraged in envenomated patients [1, 7] .
261
The use of prophylactic antibiotics in cases of snakebite is not appropriate [31] [32] [33] Snakebite is an occupational health hazard that affects mainly rural farmers. Healthcare 283 professionals still use non-guideline treatment approaches that may be harmful. Whilst
284
intensifying efforts at ensuring the continuous availability of effective antivenoms, there is the 285 need for the development and adherence to contextually relevant protocols that take into 286 consideration the prevailing local conditions. This will encourage the use of evidenced-based 287 approaches in snakebite management whilst avoiding the unwarranted use of non-beneficial 288 medications. 
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